Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. is a clinical research site located in South Bend, Indiana, United States 46617.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. has participated in 3 clinical trials.
Therapeutic areas: PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation, Solid Tumor.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Indiana · View every site in South Bend
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. has 3 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation, Solid Tumor.
Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.